Concepedia

D. M. Meyer

DM

2

Publications

162

Citations

2

H-Index

1998

Active since

Affiliations

Monsanto (United States)(Current)

D. M. Meyer is an author at Monsanto (United States) specializing in drug discovery, pharmacotherapy, and cell biology.

Top concepts

Publications per year

1998–2000

2

Publications

2

A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.

Cathy Carron, D. M. Meyer, J A Pegg et al. · PubMed · 1998 · 108 citations

, , +13

Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone

C.P. Carron, D. M. Meyer, V. Wayne Engleman et al. · Journal of Endocrinology · 2000 · 54 citations · Full text

, , +20

Rows per page

1–2 of 2